{"version":"1.0","type":"link","title":"Phase 1 Trial of BCL-2 Inhibitor Lisaftoclax (APG-2575) in Chinese Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Other Non-Hodgkin Lymphomas.","author_name":"Sun M 외","author_url":"https://prs-insight.online/author/Sun%20M","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/160077","thumbnail_width":1200,"thumbnail_height":630}